TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05953090: VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Sponsor: Stratpharma AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 2000 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT05953090 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05953090 Rescue Dossier →